Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06880627 · ClinicalTrials.gov registry record · NA

Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

A NA study of Scleroderma, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT06880627 is a NA study of Scleroderma that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 66 participants, below the 400-participant average among 23 other Scleroderma trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06880627, a NA study of Scleroderma, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all cognitive function measures, non-cognitive symptoms, and self-management compared to those in the waitlist control.

Conditions Studied

Scleroderma

Interventions

  • BEHAVIORAL Brain Boost group
  • OTHER Waitlist group

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2025-04-16
Est. Completion 2027-06
Phase NA

Sponsor

University of Michigan

1,327 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06880627

The ClinicalTrials.gov registry entry for NCT06880627 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 400-participant average among 23 other Scleroderma trials with a reported enrollment target (83% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Scleroderma appearing as the primary indexed condition, and to 2 interventions - of which Brain Boost group is the first listed.

NCT06880627 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06880627 about?

NCT06880627 is a clinical study titled "Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis". The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements im...

What is the current status of trial NCT06880627?

This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-04-16. Estimated completion is 2027-06.

What conditions does trial NCT06880627 study?

This clinical trial studies the following conditions: Scleroderma.

What interventions are being tested in trial NCT06880627?

The interventions under investigation include: Brain Boost group (BEHAVIORAL), Waitlist group (OTHER).

Who is sponsoring clinical trial NCT06880627?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06880627 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Scleroderma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Scleroderma

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.